Adimmune Corporation (4142.TW)
Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.
16.55+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-3.8%
The outlook
Adimmune Corporation currently reads as bearish based on below its 50- & 200-day averages, 2% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$6.98B
52-wk high
22.50
52-wk low
16.40
50-day avg
17.32
200-day avg
18.37
Trailing P/E
—